L G Downs

571 total citations
16 papers, 463 citations indexed

About

L G Downs is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, L G Downs has authored 16 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Cardiology and Cardiovascular Medicine and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in L G Downs's work include Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers), Peroxisome Proliferator-Activated Receptors (3 papers) and Metabolism and Genetic Disorders (2 papers). L G Downs is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers), Peroxisome Proliferator-Activated Receptors (3 papers) and Metabolism and Genetic Disorders (2 papers). L G Downs collaborates with scholars based in United Kingdom and South Sudan. L G Downs's co-authors include C. Bolton, Mike Mackness, Jonathan Pinkney, Jeremy Dwight, Charles Tomson, Sheila Crispin, J. M. Wills, J. W. G. Yarnell, M L Burr and P M Sweetnam and has published in prestigious journals such as Nephrology Dialysis Transplantation, Biochemical Society Transactions and Diabetic Medicine.

In The Last Decade

L G Downs

15 papers receiving 438 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L G Downs United Kingdom 10 119 117 115 103 60 16 463
T. Mountokalakis Greece 11 68 0.6× 126 1.1× 105 0.9× 48 0.5× 53 0.9× 44 446
Nobuharu Fujiwara Japan 15 110 0.9× 110 0.9× 83 0.7× 123 1.2× 95 1.6× 19 497
Mai Ots Estonia 13 269 2.3× 228 1.9× 82 0.7× 91 0.9× 38 0.6× 19 579
D. Travia Italy 10 147 1.2× 98 0.8× 90 0.8× 161 1.6× 89 1.5× 17 451
S Yeung Australia 8 99 0.8× 77 0.7× 50 0.4× 136 1.3× 23 0.4× 9 365
Takahiro Yamaji Japan 13 139 1.2× 81 0.7× 74 0.6× 131 1.3× 52 0.9× 28 520
Meital Cohen-Mazor Israel 8 81 0.7× 96 0.8× 73 0.6× 43 0.4× 69 1.1× 10 413
Thomas G. Elliott Canada 12 144 1.2× 174 1.5× 103 0.9× 365 3.5× 112 1.9× 28 728
Soaira G. Mendoza United States 10 52 0.4× 119 1.0× 119 1.0× 310 3.0× 51 0.8× 11 582
Kazuhiko Kotani Japan 15 46 0.4× 182 1.6× 149 1.3× 68 0.7× 39 0.7× 50 597

Countries citing papers authored by L G Downs

Since Specialization
Citations

This map shows the geographic impact of L G Downs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L G Downs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L G Downs more than expected).

Fields of papers citing papers by L G Downs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L G Downs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L G Downs. The network helps show where L G Downs may publish in the future.

Co-authorship network of co-authors of L G Downs

This figure shows the co-authorship network connecting the top 25 collaborators of L G Downs. A scholar is included among the top collaborators of L G Downs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L G Downs. L G Downs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Bolton, C., L G Downs, Jeremy Dwight, et al.. (2001). Endothelial dysfunction in chronic renal failure: roles of lipoprotein oxidation and pro‐inflammatory cytokines. Nephrology Dialysis Transplantation. 16(6). 1189–1197. 233 indexed citations
2.
Sweetnam, P M, C. Bolton, L G Downs, et al.. (2000). Apolipoproteins A–I, A–II and B, lipoprotein(a) and the risk of ischaemic heart disease: the Caerphilly Study. European Journal of Clinical Investigation. 30(11). 947–956. 41 indexed citations
3.
Moore, W., et al.. (2000). Measurement ofN-methyl-2-pyridone-5-carboxamide in urine by high performance liquid chromatography. Biomedical Chromatography. 14(2). 69–71. 9 indexed citations
4.
Pinkney, Jonathan, et al.. (1999). Endothelial dysfunction in Type 1 diabetes mellitus: relationship with LDL oxidation and the effects of vitamin E. Diabetic Medicine. 16(12). 993–999. 25 indexed citations
5.
Downs, L G, et al.. (1997). The effect of dietary changes on plasma lipids and lipoproteins of six Labrador Retrievers. Research in Veterinary Science. 63(2). 175–181. 16 indexed citations
6.
Bolton, Colin H., Alison Leaf, & L G Downs. (1997). Antioxidant defences and lipid peroxidation in preterm infants. Biochemical Society Transactions. 25(3). 522S–522S. 1 indexed citations
7.
Downs, L G, et al.. (1997). The influence of lifestyle and diet on the lipoprotein profile of Border Collies. Research in Veterinary Science. 63(1). 35–42. 11 indexed citations
8.
Downs, L G, et al.. (1994). Changes in plasma lipoprotein during the oestrous cycle of the bitch. Research in Veterinary Science. 56(1). 82–88. 13 indexed citations
9.
Downs, L G, C. Bolton, Sheila Crispin, & J. M. Wills. (1993). Plasma lipoprotein lipids in five different breeds of dogs. Research in Veterinary Science. 54(1). 63–67. 33 indexed citations
10.
Gillatt, David, et al.. (1993). Lipoprotein Levels Following Treatment with Cyproterone Acetate or LHRH Analogues. British Journal of Urology. 71(6). 728–730. 12 indexed citations
11.
Crispin, Sheila, C. Bolton, & L G Downs. (1992). Plasma lipid and lipoprotein profile of working and pet border collies. Veterinary Record. 130(9). 185–186. 12 indexed citations
12.
Bolton, Colin H., L G Downs, & Sheila Crispin. (1990). Plasma lipoproteins of normal Golden Retrievers. Biochemical Society Transactions. 18(5). 1004–1005. 8 indexed citations
13.
Downs, L G, et al.. (1989). Effect of reduced phytate wheat bran on zinc absorption.. PubMed. 43(6). 431–40. 7 indexed citations
14.
Bolton, C., Eithne Mulloy, J. Harvey, L G Downs, & M. Hartog. (1989). Plasma and Lipoprotein Lipids and Apolipoproteins AI, AII and B in Patients with Chronic Airflow Limitation. Journal of the Royal Society of Medicine. 82(2). 91–92. 9 indexed citations
15.
Burr, M L, et al.. (1989). Coffee, blood pressure and plasma lipids: a randomized controlled trial.. PubMed. 43(7). 477–83. 30 indexed citations
16.
Crispin, Sheila, C. Bolton, & L G Downs. (1988). The Relationships Between Plasma Lipoproteins: And Corneal Lipid Depositions in Dogs. Clinical Science. 74(s18). 12P–12P. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026